<DOC>
	<DOCNO>NCT00628095</DOCNO>
	<brief_summary>CE-224,535 known block chemical act gateway immune cell . Blocking gateway prevents cell push 2 chemical call IL-1 IL-18 known cause inflammation see rheumatoid arthritis . It hop take drug reduce symptom rheumatoid arthritis</brief_summary>
	<brief_title>Study CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With Methotrexate</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Active rheumatoid arthritis Incomplete response methotrexate Must biologic therapies No recent infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>rheumatoid arthritis DMARD methotrexate</keyword>
</DOC>